3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
10
Lung Neoplasms
5
Prostatic Neoplasms
4
Breast Neoplasms
4
Oropharyngeal Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia
1
Pleuropulmonary blastoma
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Pancreatitis, Chronic
1
Obesity
1
Neurocognitive Disorders
1
Neuroblastoma
1
Neoplasm Metastasis
1
Interventions
Gemcitabine
9
Cisplatin
9
pembrolizumab
5
durvalumab
3
Specimen Handling
3
Platinum
3
Oxaliplatin
3
Leucovorin
3
1,2-diaminocyclohexaneplatinum II citrate
3
Taxes
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Folfox protocol
2
Fluorouracil
2
Biopsy
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trastuzumab deruxtecan
1
peposertib
1
dehydroftorafur
1
binimetinib
1
avelumab
1
Trastuzumab
1
Tegafur
1
S 1 (combination)
1
Radiation Dose Hypofractionation
1
Radiation
1
Paclitaxel
1
Lymph Node Excision
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Observation
×
90 days
×
Clear all
No trials found.